Lung Cancer Trial, Not Yet Recruiting NCT07698990 Sponsor: Shanghai Chest Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT07698990
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 18 and 80 years.
  • People who have a single small spot on the lung (no larger than 2 cm across), confirmed by a detailed CT scan and 3D imaging reconstruction.
  • People whose lung spot is mostly solid in appearance, based on specific measurements from the CT scan.
  • People whose lung spot is located deep within the lung — specifically, in the inner two-thirds of the lung — as seen on imaging from multiple angles.
  • People whose lung spot is strongly suspected to be a type of lung cancer called non-small cell lung cancer (NSCLC), based on a full set of pre-surgery tests and specialist team review, with an estimated chance of being cancer of 95% or higher.
  • People who have had complete cancer staging tests — including detailed chest CT, a whole-body PET-CT scan, brain imaging, and blood tumour marker tests — and whose cancer is confirmed to be at an early stage (stage IA) with no spread to lymph nodes or other parts of the body.
  • People whose heart and lung function is strong enough to safely undergo either of the two types of surgery being studied, based on specific breathing test results (FEV1 and DLCO both at 60% or more of the expected level).
  • People who are willing and able to provide written consent, including acknowledgement that the final lab results after surgery may show the spot is not cancerous.
  • People whose imaging has been reviewed and approved by the trial's central technical committee before being randomly assigned to a treatment group.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose lung spot is located in a specific part of the right lung called the right middle lobe.
  • People whose lung spot, although located deep in the lung, is near the very top or bottom of the lung and is considered more suitable for a simpler type of surgery called wedge resection.
  • People who have two or more lung spots that each require a major type of surgery (anatomic resection); having one smaller secondary spot that only needs a minor removal procedure may be acceptable, but having two main spots in the same lung segment is not (confirm with trial site).
  • People who have previously had surgery on the same side of the lung being studied, or who have had another cancer diagnosed within the past 5 years.
  • People with serious heart or brain blood vessel disease, or other significant health conditions, that would make the planned surgery or any need to change to a more extensive surgery unsafe.
  • People for whom a specific type of lung segment removal involving the lower segments of the lung (called basal segmentectomy, involving segments S7–S10) is planned.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Shanghai Chest Hospital
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
1 July 2034

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov